Profil
Bart De Taeye is Director at Aelin Therapeutics NV since 2022.
Dr. De Taeye is Head of Life Sciences & Care at Participatiemaatschappij Vlaanderen NV starting in 2026.
Dr. De Taeye is Board Member at Augustine Therapeutics NV since 2023.
Dr. De Taeye is Board Member at AstriVax NV since 2022.
Dr. De Taeye earned a doctorate from Katholieke Universiteit Leuven in 2004.
Aktive Positionen von Bart De Taeye
| Unternehmen | Position | Beginn |
|---|---|---|
Participatiemaatschappij Vlaanderen NV
Participatiemaatschappij Vlaanderen NV Investment ManagersFinance PMV invests in companies located in Belgium. The firm focuses on a broad range of sectors and industries. It participates in equity and debt in seed stage, early stage, late stage and growth stage transactions with an investment size up to EUR 20 million. It consider minority investments and also makes co-investments. | Private Equity Investor | 01.04.2022 |
Augustine Therapeutics NV
Augustine Therapeutics NV Medical/Nursing ServicesHealth Services Provides therapies for tooth and neuromuscular diseases | Direktor/Vorstandsmitglied | 01.04.2023 |
Aelin Therapeutics NV
Aelin Therapeutics NV Pharmaceuticals: MajorHealth Technology Develops drugs for antibiotics and first-in-class therapeutics | Direktor/Vorstandsmitglied | 01.09.2022 |
AstriVax NV
AstriVax NV BiotechnologyHealth Technology Develops vaccine technologies | Direktor/Vorstandsmitglied | 01.07.2022 |
Ausbildung von Bart De Taeye
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Participatiemaatschappij Vlaanderen NV
Participatiemaatschappij Vlaanderen NV Investment ManagersFinance PMV invests in companies located in Belgium. The firm focuses on a broad range of sectors and industries. It participates in equity and debt in seed stage, early stage, late stage and growth stage transactions with an investment size up to EUR 20 million. It consider minority investments and also makes co-investments. | Finance |
Katholieke Universiteit Leuven
Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aelin Therapeutics NV
Aelin Therapeutics NV Pharmaceuticals: MajorHealth Technology Develops drugs for antibiotics and first-in-class therapeutics | Health Technology |
Augustine Therapeutics NV
Augustine Therapeutics NV Medical/Nursing ServicesHealth Services Provides therapies for tooth and neuromuscular diseases | Health Services |
AstriVax NV
AstriVax NV BiotechnologyHealth Technology Develops vaccine technologies | Health Technology |
















